Beck E J, Mandalia S, Williams I, Power A, Newson R, Molesworth A, Barlow D, Easterbrook P, Fisher M, Innes J, Kinghorn G, Mandel B, Pozniak A, Tang A, Tomlinson D
NPMS Coordinating and Analytic Centre, Chelsea and Westminster Hospital, London, UK.
AIDS. 1999 Oct 22;13(15):2157-64. doi: 10.1097/00002030-199910220-00020.
To investigate the relationship between changing morbidity patterns, the use of hospital services by HIV-infected patients and the uptake of antiretroviral therapy (ART) in England.
Prospective serial cross-sectional analyses based on data collected through the National Prospective Monitoring System (NPMS), a multi-centre prospective monitoring system.
HIV-infected patients seen in 10 clinics, five London and five non-London, during the three semesters, 1 January 1996 to 30 June 1997.
The mean use of hospital services per patient-year, mean new HIV-related opportunistic illnesses per 1000 patient-years and percentage uptake of ART.
The use of inpatient services changed particularly among AIDS patients. The mean number of inpatient days for AIDS patients decreased from 19.7 [95% confidence interval (CI) 13.7-25.7] in 1996 to 11.2 (95% CI 6.1-15.6) per patient-year in 1997. Concurrently the number of new AIDS-defining events decreased significantly from 567 (95% CI 529-607) to 203 (95% CI 183-225) per 1000 patient-years. The overall uptake of ART increased significantly from 33% (95% CI 31-35%) to 50% (95% CI 48-52%), and a switch from mono or dual to triple therapy or quadruple or more therapy was observed. However, by mid-1997 only 29% (95% CI 26-32%) of asymptomatic patients and 51% (95% CI 49-54%) of patients with symptomatic non-AIDS were on ART, compared with 69% (95% CI 66-71%) of AIDS patients.
The observed reduction in new AIDS-defining events has led to a reduction in the need for inpatient hospital care and has been associated with an increased uptake of ART, including a switch to triple therapy. All of these factors are likely to have contributed to the observed reduction in mortality among English AIDS patients. As the overall uptake of ART remained relatively low in English centres further improvements can be anticipated. However, the medium to long-term effects of these treatment regimens will need to be closely monitored.
调查英国发病率模式变化、艾滋病毒感染患者对医院服务的利用情况以及抗逆转录病毒疗法(ART)的使用之间的关系。
基于通过国家前瞻性监测系统(NPMS,一个多中心前瞻性监测系统)收集的数据进行前瞻性系列横断面分析。
1996年1月1日至1997年6月30日的三个学期期间,在10家诊所(伦敦5家,非伦敦5家)就诊的艾滋病毒感染患者。
每位患者每年使用医院服务的平均次数、每1000患者年新出现的与艾滋病毒相关的机会性疾病的平均数以及ART的使用比例。
住院服务的使用情况在艾滋病患者中变化尤为明显。艾滋病患者的平均住院天数从1996年的19.7天[95%置信区间(CI)13.7 - 25.7]降至1997年的每位患者每年11.2天(95%CI 6.1 - 15.6)。与此同时,每1000患者年新出现的艾滋病定义事件数量从567例(95%CI 529 - 607)显著降至203例(95%CI 183 - 225)。ART的总体使用比例从33%(95%CI 31 - 35%)显著增至50%(95%CI 48 - 52%),并且观察到从单一或双重疗法转向三联疗法或四联及以上疗法的情况。然而,到1997年年中,只有29%(95%CI 26 - 32%)的无症状患者和51%(95%CI 49 - 54%)的有症状非艾滋病患者接受ART治疗,而艾滋病患者的这一比例为69%(95%CI 66 - 71%)。
观察到的新艾滋病定义事件的减少导致了住院医疗需求的降低,并与ART使用的增加相关,包括转向三联疗法。所有这些因素可能都促成了英国艾滋病患者死亡率的下降。由于英国各中心ART的总体使用比例仍然相对较低,可以预期会有进一步的改善。然而,这些治疗方案的中长期效果需要密切监测。